Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
586 studies found for:    "Homologous wasting disease"
Show Display Options
Rank Status Study
1 Active, not recruiting Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Conditions: Graft Versus Host Disease;   Steroid Refractory GVHD;   Acute GVH Disease
Intervention: Drug: Infliximab and Basiliximab
2 Completed Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Chronic Graft vs Host Disease;   cGVHD
Intervention:
3 Completed Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.
Conditions: Graft Versus Host Disease;   Chronic and Expanded Graft Versus Host Disease;   Immune System Diseases
Intervention: Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
4 Recruiting An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-Host-Disease;   Oral Mucosal Disease Due to Graft-versus-host Disease
Intervention: Drug: Sirolimus
5 Recruiting Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD
Conditions: Chronic Graft vs. Host Disease;   Graft vs Host Disease;   Graft-Versus-Host Disease
Interventions: Procedure: Extracorporeal Photopheresis (ECP);   Drug: Methoxsalenused in conjuction with photopheresis procedure
6 Recruiting Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Conditions: Chronic Graft-Versus-Host Disease;   Acute Graft-Versus-Host Disease;   Steroid Refractory Graft-Versus-Host Disease
Interventions: Drug: Rapamycin;   Other: T regulatory cells
7 Recruiting Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
Conditions: Acute Graft-versus-host Disease;   Acute GVHD;   Chronic Graft-versus-host Disease;   Chronic GVHD
Interventions: Procedure: Skin punch biopsy;   Procedure: Peripheral blood draw
8 Completed Experience of Having Chronic Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
9 Enrolling by invitation Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Intervention:
10 Withdrawn Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract
Conditions: Acute Graft Versus Host Disease;   Intestinal Graft Versus Host Disease
Interventions: Drug: Budesonide;   Drug: Methylprednisolone Sodium Succinate
11 Not yet recruiting Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Graft vs Host Disease;   Chronic Graft-Versus-Host Disease
Intervention: Drug: Baricitinib
12 Withdrawn Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease
Condition: Graft-Versus-Host-Disease
Intervention:
13 Completed A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
Conditions: Bone Marrow Transplantation;   Graft Versus Host Disease;   Graft-Versus-Host Disease;   Graft-Vs-Host Disease
Intervention: Drug: Tacrolimus
14 Terminated Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Tocilizumab
15 Completed Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Rituximab
16 Recruiting BMT Auto MSCs GvHD Ph 1
Conditions: Graft Versus Host Disease;   Acute Graft Versus Host Disease;   Chronic Graft Versus Host Disease
Intervention: Biological: Autologous mesenchymal stromal cells (MSCs)
17 Active, not recruiting Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Condition: Graft Versus Host Disease
Intervention: Drug: Ibrutinib
18 Terminated A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
Condition: Graft Versus Host Disease
Intervention: Drug: Rituximab
19 Unknown  Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Condition: Graft vs Host Disease
Intervention: Drug: Atorvastatin calcium (Lipitor)
20 Active, not recruiting
Has Results
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Condition: Graft vs. Host Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo;   Drug: Tacrolimus (TAC);   Drug: Sirolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years